Corinne Jenkins
Stock Analyst at Goldman Sachs
(4.2)
Main Sectors:
Top Industries:
19 Stocks
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
RYTM Rhythm Pharmaceutica... | Maintains: Strong Buy | 105 138 | 99.02 | 39.37% | 9 | Sep 24, 2025 | |
ROIV Roivant Sciences | Maintains: Strong Buy | 20 24 | 16.17 | 48.42% | 6 | Sep 18, 2025 | |
GERN Geron | Reinstates: Sell | 1 | 1.35 | -25.93% | 4 | Jul 10, 2025 | |
TGTX TG Therapeutics | Maintains: Neutral | 20 22 | 36.7 | -40.05% | 8 | Nov 5, 2024 | |
ITCI Intra-Cellular Thera... | Maintains: Neutral | 77 74 | n/a | n/a | 5 | Aug 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 6 15 | 9.22 | 62.69% | 2 | May 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 53 46 | 27.64 | 66.43% | 5 | May 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Neutral | 13 | 3.91 | 232.48% | 3 | Jan 24, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 25 28 | 27.28 | 2.64% | 7 | Jan 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 47 52 | n/a | n/a | 5 | Nov 29, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 10 9 | n/a | n/a | 5 | Nov 15, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 332 296 | n/a | n/a | 2 | Nov 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 192 64 | 2.53 | 2429.64% | 6 | Aug 15, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 216 184 | 30.14 | 510.48% | 2 | Mar 15, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 25 21 | 1.86 | 1029.03% | 2 | Mar 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 9 14 | 8.23 | 70.11% | 2 | Dec 20, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 2 | n/a | n/a | 1 | Aug 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 9 8 | n/a | n/a | 2 | May 24, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 160 | 4.14 | 3764.73% | 2 | Dec 15, 2021 |